Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Found microRNA differences in hair cells, suggesting potential treatment targets for hair loss.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

Phyllanthus urinaria extract may help treat hair loss by blocking a hair-related enzyme.

BeauTop improves hair growth in androgenetic alopecia patients.

Breadfruit is nutritious and has potential health and medicinal benefits, but is currently underused.

Skin aging reflects overall body aging and can indicate internal health conditions.

Eat a balanced diet for healthy hair; only use supplements if you have a proven nutrient deficiency.

Found key genes affecting hair loss, immune response, and skin development; more research needed for better treatments.

Hair loss is more common in men aged 18-49 and increases with age.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Ostrich antibodies can help restore hair growth in people with a specific type of hair loss, increasing hair count by 71% on average.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Grateloupia elliptica extract may help prevent hair loss and promote hair growth.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.